Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Review of the Historical Literature and Its Role in the Era of Targeted Molecular Therapy

Renal cell carcinoma presents with metastatic disease in approximately 30% cases. While surgical intervention remains the standard of care for organ confined disease, its role is limited in the management of metastatic disease. Over the last decade, cytoreductive nephrectomy prior to immunotherapy h...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Muhammad Z., Matthews, P. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922000/
https://www.ncbi.nlm.nih.gov/pubmed/24587921
http://dx.doi.org/10.1155/2014/717295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922000/
https://www.ncbi.nlm.nih.gov/pubmed/24587921
http://dx.doi.org/10.1155/2014/717295

Ejemplares similares